| Study to Compare (COPD) Assessment Test in COPD Stage III and IV in a Prophylactic Treatment (NCT01679314) | ElectroCore INC | 2012-07-01 |
| Walking Speeds in Patients With Chronic Obstructive Pulmonary Disease (NCT01768754) | West Park Healthcare Centre | 2012-07-01 |
| Longitudinal Study of Oscillatory Positive Expiratory Pressure (oPEP) in Stable COPD (NCT02282189) | Western University, Canada | 2012-07-01 |
| N-Acetylcysteine for Patients With COPD and ChronicBronchitis (NCT01599884) | Center for Veterans Research and Education | 2012-06-01 |
| A RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology (NCT02307799) | Université Catholique de Louvain | 2012-06-01 |
| Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01613326) | Novartis Pharmaceuticals | 2012-06-01 |
| Effects of Laser Therapy on Muscle Function in COPD Patients (NCT01448564) | Eduardo Foschini Miranda | 2012-06-01 |
| Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen. (NCT01541852) | Cambridge University Hospitals NHS Foundation Trust | 2012-06-01 |
| Influence of Chronic Hypoxia on Oxidative Phenotype in Patients With Chronic Obstructive Pulmonary Disease (NCT02532426) | Centre Hospitalier Universitaire de Saint Etienne | 2012-05-18 |
| Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease (NCT01595750) | Spanish Research Center for Respiratory Diseases | 2012-05-01 |
| Substudy : Patients With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease (NCT02282436) | Laval University | 2012-05-01 |
| Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01529632) | Novartis Pharmaceuticals | 2012-05-01 |
| Promoting Physical Activity in Chronic Obstructive Pulmonary Disease (COPD) Through New Technology and Health Coaching (NCT01217710) | Mayo Clinic | 2012-04-01 |
| The Role of Substance P on Perception of Breathlessness During Resistive Load Breathing (NCT01580423) | Dartmouth-Hitchcock Medical Center | 2012-04-01 |
| Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD) (NCT01572792) | AstraZeneca | 2012-04-01 |
| Corticosteroids and Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation (NCT01798420) | The Nazareth Hospital, Israel | 2012-04-01 |
| Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD (NCT02123199) | Novartis Pharmaceuticals | 2012-04-01 |
| Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (NCT01513460) | Novartis Pharmaceuticals | 2012-04-01 |
| Antioxidants and Pulmonary Rehabilitation in COPD Patients (NCT01942889) | University Hospital, Montpellier | 2012-04-01 |
| Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT01587079) | Pearl Therapeutics, Inc. | 2012-04-01 |
| Safety Study to Evaluate MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01551316) | MediciNova | 2012-03-01 |
| Pursed-lips Breathing and Dynamic Hyperinflation (NCT02203058) | University of the State of Santa Catarina | 2012-03-01 |
| Manual Therapy in Chronic Obstructive Pulmonary Disease (NCT02534831) | University of Chile | 2012-03-01 |
| Non-invasive Assessment of Pulmonary Vascular Resistance in Elderly Patients With Chronic Obstructive Pulmonary Disease (NCT01554774) | Hospital Viamed Valvanera, Spain | 2012-03-01 |
| PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD (NCT01566773) | Pearl Therapeutics, Inc. | 2012-03-01 |
| Metabolic Changes in Patients With Chronic Cardiopulmonary Disease (NCT02550808) | General and Teaching Hospital Celje | 2012-03-01 |
| Development of the Partial Pressure of Carbon Dioxide During Exercise and at Night in Patients With Chronic Obstructive Pulmonary Disease (COPD) IV (NCT01696916) | Schön Klinik Berchtesgadener Land | 2012-03-01 |
| Use of an Air Warming Mask for Exercise in Patients With COPD V1.0 (NCT02266316) | University of Worcester | 2012-03-01 |
| Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD) (NCT01437878) | Actelion | 2012-03-01 |
| Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary Disease (NCT01509677) | AstraZeneca | 2012-02-01 |
| A Study to Investigate the Effects of Heated Humidification During Non-Invasive Ventilation (NCT01372072) | Guy's and St Thomas' NHS Foundation Trust | 2012-02-01 |
| Feel Breathe, Restriction Device Ventilatory Nasal (COPD) (NCT01695265) | University of Cadiz | 2012-02-01 |
| Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.) (NCT01555138) | Novartis Pharmaceuticals | 2012-02-01 |
| Prevalence Study and Regular Practice Among General Practitioners in Populations at Risk of Chronic Obstructive Pulmonary Disease (COPD) in Latin America (NCT01493544) | AstraZeneca | 2012-02-01 |
| The Effects of Aerobic Exercise Training on Vascular, Cardiac and Cerebral Vascular Function in COPD (NCT02875522) | University of British Columbia | 2012-01-01 |
| Proprioceptive Postural Control and Chronic Obstructive Pulmonary Disease (COPD) (NCT01505543) | KU Leuven | 2012-01-01 |
| Spontaneous Breathing Trials Using Pressure-Support or T-Tube in Chronic Obstructive Pulmonary Disease Patients Weaning Mechanical Ventilation (NCT01464567) | Hospital Nossa Senhora da Conceicao | 2012-01-01 |
| Human Immunodeficiency Virus (HIV)and Chronic Obstructive Pulmonary Disease (COPD) (NCT01639274) | Centre Hospitalier Universitaire de Nice | 2012-01-01 |
| Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease (NCT01499433) | The First Affiliated Hospital of Guangzhou Medical University | 2012-01-01 |
| Home-based in Chronic Obstructive Pulmonary Disease (NCT01554072) | University of Nove de Julho | 2012-01-01 |
| Respiratory Physiology Under High Flow Therapy (NCT01509703) | Institut für Pneumologie Hagen Ambrock eV | 2011-12-01 |
| Home Non Invasive Ventilation for COPD Patients (NCT03221101) | University Hospital, Rouen | 2011-12-01 |
| Location and Timing of Inhaler Use, Exacerbations and Physical Activity in Chronic Obstructive Pulmonary Disease (NCT02661321) | VA Puget Sound Health Care System | 2011-12-01 |
| Home Non-invasive Ventilation for Chronic Obstructive Pulmonary Disease Patients (NCT01526642) | University Hospital, Rouen | 2011-12-01 |
| Feasibility and Effectiveness of Telehealth in Patients With Chronic Obstructive Pulmonary Disease in Taiwan (NCT01724684) | National Taiwan University Hospital | 2011-12-01 |
| Fibre Specific Signalling in the Locomotor Myopathy of Chronic Obstructive Pulmonary Disease (NCT01471587) | Royal Brompton & Harefield NHS Foundation Trust | 2011-12-01 |
| Continuous Positive Airway Pressure Versus Noninvasive Ventilation in Patients With Overlap Syndrome (NCT01427673) | United States Air Force | 2011-12-01 |
| Exacerbation Prevention GOLD IV COPD With Non Invasive Mechanical Ventilation (NCT01481727) | National Institute of Respiratory Diseases, Mexico | 2011-12-01 |
| Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching (NCT01494896) | University of Florida | 2011-11-01 |
| A Study to Investigate How Safe and Well Tolerated RV568 is in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01475292) | Respivert Ltd | 2011-11-01 |
| A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease (NCT01448850) | MedImmune LLC | 2011-11-01 |
| Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients (NCT01470274) | Norwegian University of Science and Technology | 2011-11-01 |
| Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in China (NCT01455129) | The First Affiliated Hospital of Guangzhou Medical University | 2011-11-01 |
| Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2 (NCT01624792) | Texas A&M University | 2011-10-25 |
| The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01490125) | Novartis Pharmaceuticals | 2011-10-01 |
| Benefits and Costs of Home-based Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (NCT01423227) | La Trobe University | 2011-10-01 |
| Evaluating Sequential Strategies to Reduce Readmission in a Diverse Population (NCT01619098) | Alison Galbraith | 2011-10-01 |
| Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic Obstruct (NCT01426893) | AstraZeneca | 2011-10-01 |
| Effect of Inspiratory Muscle Training on Exercise Performance and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (NCT02257463) | Mansoura University | 2011-10-01 |
| Mindfulness Mediation Intervention in Chronic Obstructive Pulmonary Disease (COPD) (NCT01577329) | University of Michigan | 2011-10-01 |
| COPE With COPD Trial (NCT02343055) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2011-10-01 |
| Anxiety and Depression in Patients Hospitalizes for an Acute Exacerbation of COPD (NCT01520376) | Nestor Soler Porcar, MD, PhD | 2011-10-01 |
| Effects of Inspiratory Muscle Training on Dyspnea in Subjects With Chronic Obstructive Pulmonary Disease (NCT01545011) | University Hospital, Brest | 2011-10-01 |
| Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT01437540) | AstraZeneca | 2011-09-19 |
| Study of Use of CTC in NSCLC (NCT01990651) | University of Virginia | 2011-09-01 |
| Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients (NCT01382368) | Rabin Medical Center | 2011-09-01 |
| Muscle Atrophy In Patients With Chronic Obstructive Pulmonary Disease (NCT02284932) | Laval University | 2011-09-01 |
| Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF) (NCT01424137) | Orion Corporation, Orion Pharma | 2011-09-01 |
| Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01437397) | AstraZeneca | 2011-09-01 |
| A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR) (NCT01351792) | Chiesi Farmaceutici S.p.A. | 2011-09-01 |
| Effects of IPV Assessed With Functional Imaging (NCT01671540) | University Hospital, Antwerp | 2011-09-01 |
| Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD (NCT01393145) | Ache Laboratorios Farmaceuticos S.A. | 2011-08-01 |
| Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study (NCT01426009) | Sunovion Respiratory Development Inc. | 2011-08-01 |
| Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease (NCT01949181) | Hopital Foch | 2011-08-01 |
| Balance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01424098) | Roger Goldstein | 2011-08-01 |
| Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Emphysema (NCT01305668) | Villa Pineta Hospital | 2011-08-01 |
| Muscle Dysfunction in Patients With Chronic Obstructive Lung Disease (COPD): the Role of Sympathetic Activation (NCT01750489) | University Medical Center Goettingen | 2011-08-01 |
| Effects of an Inpatient Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease (COPD) III/IV (NCT01418768) | Schön Klinik Berchtesgadener Land | 2011-08-01 |
| The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV (NCT01478646) | Schön Klinik Berchtesgadener Land | 2011-08-01 |
| Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary Disease (NCT01372462) | Breathe Technologies, Inc. | 2011-07-01 |
| Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease (NCT01391559) | Dartmouth-Hitchcock Medical Center | 2011-07-01 |
| Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease (NCT01369810) | AstraZeneca | 2011-07-01 |
| Effectiveness of Respiratory Muscle Training by Spirotiger in Chronic Patients (NCT01556139) | Fondazione Salvatore Maugeri | 2011-06-01 |
| Effect of Ketoconazole on Breathlessness (NCT01378520) | Dartmouth-Hitchcock Medical Center | 2011-06-01 |
| Physiological and Clinical Changes in NHF Therapy (NCT02504814) | University of Leipzig | 2011-06-01 |
| Characteristics That Identify Exacerbation Risk Following Colds in COPD Patients (NCT01376830) | Imperial College London | 2011-06-01 |
| PT003 MDI Dose Confirmation Study (NCT01349816) | Pearl Therapeutics, Inc. | 2011-06-01 |
| Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography (NCT01361984) | University of California, Los Angeles | 2011-06-01 |
| Pharmacokinetic Study of Single and Repeated Dose of Roflumilast 500 µg , in Healthy Chinese Subjects (NCT01354782) | AstraZeneca | 2011-05-01 |
| PT005 MDI Dose Ranging Versus Foradil Aerolizer Study (NCT01349868) | Pearl Therapeutics, Inc. | 2011-05-01 |
| Phenotypes and Vascular Damage in Chronic Obstructive Pulmonary Disease (COPD) (NCT01527773) | University of Zurich | 2011-05-01 |
| Educational Intervention for Managing Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01380405) | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | 2011-05-01 |
| Trial of an Internet-based Platform for Managing Chronic Diseases at a Distance (NCT01342263) | Simon Fraser University | 2011-05-01 |
| PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01350128) | Pearl Therapeutics, Inc. | 2011-05-01 |
| Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in Greece (NCT02187926) | AstraZeneca | 2011-05-01 |
| PT003 MDI Cardiovascular Safety Study (NCT01349803) | Pearl Therapeutics, Inc. | 2011-05-01 |
| Chest Wall Muscle Stretching and Acute Effects in Chronic Obstructive Pulmonary Disease (NCT01826669) | Universidade Federal de Pernambuco | 2011-05-01 |
| Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS) (NCT01329029) | AstraZeneca | 2011-05-01 |
| A Study in Patients With Chronic Obstructive Pulmonary Disease (NCT01245569) | Chiesi Farmaceutici S.p.A. | 2011-04-12 |
| A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations (NCT01337661) | MedImmune LLC | 2011-04-01 |